Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-10-31FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2013-10-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-Aventis U.S. LLC. This action approves changes to…
-
FDA approval · 2013-09-06FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, expanding the regulatory approval for the product.
-
FDA approval · 2013-08-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (and its diluent) from Eli Lilly, signaling an update to the product's regulatory…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-08-21FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) to incorporate the KwikPen delivery device for the pre…
-
FDA approval · 2013-08-14FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-07-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2013-07-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2013-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. Thi…
-
FDA approval · 2013-06-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-05-31FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-05-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action authorizes changes to the produ…
-
FDA approval · 2013-05-16FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi U.S. LLC.
-
FDA approval · 2013-05-10FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company. The action approves changes un…
-
FDA approval · 2013-05-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro (Humalog) from Eli Lilly, marking an update to the product under the existing…
-
FDA approval · 2013-05-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-04-10FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2013-03-28FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-28FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. The action concerns the su…